Clinical Trial Update: The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial (SINGLE-AF) is recruiting to assess the efficacy and safety of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Yonsei University | Conditions: Atrial Fibrillation Patients With Intermediate Stroke Risk | Phase 4 | Status: RECRUITING